| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Tango Therapeutics, Inc. (TNGX) have been net sellers, shedding 89,200 shares worth roughly $2.2M on balance. In the past 30 days, 0 insiders bought and 2 sold.
Not all activity pointed one way: 2 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), TNGX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.39M | $135.90M | - | |
| CEO | 367.5K | - | - | |
| CFO | 240.0K | - | - | |
| Pres | 116.3K | $2.85M | -27,000 | |
| Other | 59.1K | $1.49M | -8,200 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 27,000 | $24.47 | $660,796.08 | -18.9% | - | - | |
| Sep 22, 2026 | Newcomb Jessica | Principal Accounting Officer | Sell | 8,200 | $24.22 | $198,612.68 | -12.2% | - | - | |
| Sep 1, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 27,000 | $22.37 | $603,909.00 | -18.9% | - | - | |
| Aug 3, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 27,000 | $27.24 | $735,517.41 | -18.9% | - | - | |
| Jul 1, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 27,000 | $29.59 | $798,908.18 | -18.9% | - | - | |
| Jun 1, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 27,000 | $22.87 | $617,571.27 | -18.9% | - | - | |
| May 1, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 27,000 | $21.23 | $573,097.33 | -18.9% | +31.4% | - | |
| Apr 15, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 38,460 | $25.00 | $961,500.00 | -25.5% | - | - | |
| Apr 1, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 27,000 | $21.20 | $572,478.30 | -19.3% | - | - | |
| Mar 25, 2026 | Crystal Adam76 | President, R&D | Sale+OE | 12,000 | $20.11 | $241,320.00 | -9.6% | +36.0% | - |